Alignment Healthcare president sells 30,000 shares
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock. The shares were sold at a weighted-average price of $20.8733 per share under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, Maroney directly holds 1,028,813 shares of Alignment Healthcare common stock. The sale was executed in multiple trades at prices ranging from $20.76 to $21.07 per share.
Insider Trade Summary 10b5-1
Net Seller: 30,000 shares
Net Sell
1 txn
Insider
Maroney Dawn Christine
Role
President
Sold
30,000 shs ($626K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,000 | $20.8733 | $626K |
Holdings After Transaction:
Common Stock — 1,028,813 shares (Direct)
Footnotes (2)
- F1. Date of Rule 10b5-1 plan adoption: 05/22/2025
- F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.76 to $21.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Key Figures
Shares sold: 30,000 shares
Weighted-average sale price: $20.8733 per share
Price range of trades: $20.76–$21.07 per share
+3 more
6 metrics
Shares sold
30,000 shares
Open-market sale of common stock on April 15, 2026
Weighted-average sale price
$20.8733 per share
Reported sale price in Form 4 column 4
Price range of trades
$20.76–$21.07 per share
Multiple transactions within this range
Shares owned after transaction
1,028,813 shares
Direct holdings following the reported sale
Net share change
30,000 shares sold
Net-sell direction per transaction summary
Rule 10b5-1 plan adoption date
05/22/2025
Footnote identifying trading plan adoption date
Key Terms
Rule 10b5-1 plan, weighted-average price, open-market sale, Form 4
4 terms
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 05/22/2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
open-market sale financial
"transaction_action: open-market sale of common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4): reporting this transaction"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Alignment Healthcare (ALHC) report on this Form 4?
Alignment Healthcare president Dawn Christine Maroney reported selling 30,000 shares of common stock in an open-market transaction. The sale was executed at a weighted-average price of $20.8733 per share across multiple trades within a disclosed price range.
Was the ALHC insider sale made under a Rule 10b5-1 trading plan?
Yes. The Form 4 states that the transaction was made pursuant to a Rule 10b5-1 trading plan adopted on 05/22/2025. Such plans pre-arrange trades, providing structure and reducing the significance of short-term market timing decisions.
Who is the insider involved in the latest ALHC Form 4 transaction?
The insider is Dawn Christine Maroney, identified as the president of Alignment Healthcare, Inc. She filed a Form 4 reporting an open-market sale of 30,000 shares of the company’s common stock, with details on pricing and remaining holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates